Pharmaceutical groups are increasingly relying on real-world data (RWD) to accelerate drug development and optimize clinical trial design. However, accessing, analyzing, and interpreting complex RWD often be challenging. Datma's Federated Biomarker Explorer provides a cutting-edge solution by presen